Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,547 | 10,220 | 20,761 | 7,165 | 5,934 |
| Depreciation Amortization | 676 | 809 | 984 | 1,172 | 1,933 |
| Income taxes - deferred | -129 | 75 | -47 | 108 | -26 |
| Accounts receivable | -51 | -226 | 36 | 577 | 164 |
| Accounts payable and accrued liabilities | 81 | 312 | -291 | 154 | -208 |
| Other Working Capital | -2,501 | 15,953 | -14,371 | -161 | -117 |
| Other Operating Activity | -108 | 316 | 1,263 | -359 | 180 |
| Operating Cash Flow | $5,515 | $27,459 | $8,335 | $8,656 | $7,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -340 | -411 | -272 | -517 | -524 |
| Net Acquisitions | N/A | -1,012 | N/A | N/A | N/A |
| Purchase Of Investment | -10,600 | -22,103 | -737 | N/A | N/A |
| Sale Of Investment | 9,045 | 8,202 | 98 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -10 | -122 | N/A | N/A |
| Other Investing Activity | 0 | -10 | -122 | 0 | 0 |
| Investing Cash Flow | $-1,895 | $-15,334 | $-1,033 | $-517 | $-524 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,336 | N/A | N/A | 4,956 | N/A |
| Debt Repayment | N/A | N/A | -4,956 | -2,501 | -7,499 |
| Common Stock Issued | 858 | 1,111 | 882 | 1,113 | 316 |
| Common Stock Repurchased | -9,437 | -10,698 | -2,795 | -11,818 | -193 |
| Dividend Paid | -2,445 | -1,331 | N/A | N/A | N/A |
| Other Financing Activity | 937 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-4,751 | $-10,918 | $-6,869 | $-8,250 | $-7,376 |
| Exchange Rate Effect | 16 | -151 | 44 | 26 | -4 |
| Beginning Cash Position | 1,818 | 762 | 285 | 370 | 414 |
| End Cash Position | 703 | 1,818 | 762 | 285 | 370 |
| Net Cash Flow | $-1,116 | $1,056 | $477 | $-85 | $-44 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,515 | 27,459 | 8,335 | 8,656 | 7,860 |
| Capital Expenditure | -345 | -411 | -272 | -517 | -524 |
| Free Cash Flow | 5,170 | 27,048 | 8,063 | 8,139 | 7,336 |